BioLife Solutions Inc
BLFS26.040USD
-0.250-0.95%
Handelsschluss 11/11, 16:00（ET）Kurse um 15 Minuten verzögert
1.25BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über BioLife Solutions Inc Unternehmen
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions Inc Informationen
BörsenkürzelBLFS
Name des UnternehmensBioLife Solutions Inc
IPO-datumNov 22, 1989
CEOMr. Roderick De Greef
Anzahl der mitarbeiter159
WertpapierartOrdinary Share
GeschäftsjahresendeNov 22
AddresseSuite 310
StadtBOTHELL
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl98021
Telefon14254011400
Websitehttps://www.biolifesolutions.com/
BörsenkürzelBLFS
IPO-datumNov 22, 1989
CEOMr. Roderick De Greef
Führungskräfte von BioLife Solutions Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.42K
-0.20%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.52K
-0.28%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
99.33K
-0.83%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.21K
-0.37%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
26.04K
-1.05%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
23.81K
-22.41%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
253.42K
-0.20%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.52K
-0.28%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
99.33K
-0.83%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
50.21K
-0.37%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
Aktionärsstatistik
Aktualisiert: Fri, Oct 10
Aktualisiert: Fri, Oct 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.55%
T. Rowe Price Investment Management, Inc.
8.82%
Invesco Advisers, Inc.
7.18%
The Vanguard Group, Inc.
6.15%
Andere
54.93%
Aktionäre
Aktionäre
Anteil
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.55%
T. Rowe Price Investment Management, Inc.
8.82%
Invesco Advisers, Inc.
7.18%
The Vanguard Group, Inc.
6.15%
Andere
54.93%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.54%
Investment Advisor/Hedge Fund
33.79%
Hedge Fund
15.59%
Research Firm
2.52%
Individual Investor
2.10%
Pension Fund
1.57%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.08%
Venture Capital
0.05%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
405
50.24M
104.42%
-1.24M
2025Q2
411
47.71M
99.74%
-5.40M
2025Q1
430
51.12M
107.57%
-1.38M
2024Q4
407
48.89M
104.05%
-2.49M
2024Q3
404
46.98M
101.82%
-6.27M
2024Q2
385
48.82M
105.97%
-2.22M
2024Q1
377
46.95M
103.67%
-5.60M
2023Q4
397
47.58M
108.04%
-4.07M
2023Q3
399
45.29M
104.13%
-2.05M
2023Q2
401
44.87M
103.50%
-2.76M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
Columbia Wanger Asset Management, LLC
997.60K
2.08%
+116.26K
+13.19%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
Invesco S&P SmallCap Health Care ETF
0.63%
Invesco S&P SmallCap 600 Pure Growth ETF
0.55%
First Trust Multi-Manager Small Cap Opportunities ETF
0.48%
Zacks Small/Mid Cap ETF
0.38%
iShares Micro-Cap ETF
0.18%
SPDR S&P 600 Small Cap Growth ETF
0.13%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.12%
iShares ESG Select Screened S&P Small-Cap ETF
0.08%
iShares Core S&P Small-Cap ETF
0.07%
Mehr Anzeigen
Invesco S&P SmallCap Health Care ETF
Anteil0.63%
Invesco S&P SmallCap 600 Pure Growth ETF
Anteil0.55%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.48%
Zacks Small/Mid Cap ETF
Anteil0.38%
iShares Micro-Cap ETF
Anteil0.18%
SPDR S&P 600 Small Cap Growth ETF
Anteil0.13%
Vanguard S&P Small-Cap 600 Growth Index Fund
Anteil0.13%
iShares S&P Small-Cap 600 Growth ETF
Anteil0.12%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.08%
iShares Core S&P Small-Cap ETF
Anteil0.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
